Case Studies

This listing contains abstracts and ordering information for case studies written and published by faculty at Stanford GSB.

Narrow your results
|P92
Pathipati, Akhilesh S, Bundorf, Mary K
2016

This case follows John Fernandez, CEO of Massachusetts Eye and Ear, as he evaluates whether or not his organization should join Partners HealthCare, the state’s largest healthcare provider. Starting in the mid-2000s, there was a...

|OB91B
Sarah Soule, Davina Drabkin
2015

The B case begins with the consultants’ proposal to Kim Markey, executive director of revenue cycle at Huntington Hospital (HH).   The proposal is untraditional in that it is focused on more than revenue enhancement—it includes...

|OB91(A)
Sarah Soule, Davina Drabkin
2015

Kim Markey began as executive director of revenue cycle at Huntington Hospital (HH) in November 2012.  Located in Pasadena, California, HH was a 625-bed non-profit regional medical center that was named among the top-performing hospitals...

|SM209C
Robert Burgelman, Robert Siegel, Rosy Lee
2014

This short case discusses the process of Life Technologies’ acquisition by Thermo Fisher in 2013 and 2014. The case is a complement to SM-209A and SM-209B, which highlight the various growth and acquisition strategies the...

|E489
Robert Chess, Jason Luther
2014

International healthcare and reimbursement systems underwent a radical transformation in the 2000s, resulting from growing financial pressures incited by economic depression and a steady rise in healthcare spending. This phenomenon was most pronounced in the...

|SM192A
Jesper Sorensen, Debra Schifrin, Kevin Hettrich
2013

The (A) case presents a 2009 critical expansion decision for health care nonprofit Health Leads: whether to expand rapidly while it had momentum, strong advocates, very high demand for its services, and funder support for...

|E419
Jeffrey Chambers, Michael Child, Arar Han
2012

TwinMed was a nursing home supply business located in Los Angeles. This case details its humble origins and its development, and raises several strategic issues prevalent in Medicare-reimbursed businesses, business-to-business selling, and what to do...

|OIT94
Robert Chess, Sara Leslie
2009

Gilead Sciences launched Truvada, a combination pill incorporating Gilead’s individual antiviral drugs, Viread and Emtriva, in the U.S. in 2004. This involved gaining FDA approval, setting a national price, and negotiating reimbursement levels with private...

|P72
Daniel Kessler, Sara Leslie
2009

In 2002, the Bush Administration launched the Hospital Quality Initiative, which was intended to improve quality through accountability and public disclosure and to “empower consumers with quality of care information to make more informed decisions...

|GS58
Hau Lee, Brian Tayan
2007

In 1996, Andrea and Barry Coleman launched Riders for Health, a United Kingdom-based nonprofit dedicated to the improvement of transportation systems for health workers in Africa. The nonprofit’s main program, Transportation Resource Management, involved a...

|SI14
Chip Heath, James Phills
2006

Established in the late 1960s, Interplast was the first international humanitarian organization to send American medical professionals overseas to provide free reconstructive surgery to children and adults in developing countries. Over the next 30 years,...

|OIT46
Lyn Denend, Stefanos Zenios
2005

By the mid-1980s, it was clear that not all transplant centers in the growing organ transplantation market were able to achieve and sustain the same levels of quality and high rates of transplant procedure success....

|BME1
Margaret Eaton, Betty Pang, Jennifer Wilds
2005

The VaxGen, Inc. case details the efforts of VaxGen and its president, Don Francis, to obtain approval to conduct phase III clinical trials in Thailand for AIDSVAX, an experimental vaccine designed to protect against human...

|IB31
Kanika Bahl, John Newsome, Joel Podolny
2002

The ballooning HIV/AIDS rate in South Africa is exacting an increasing toll on the profitability of South African businesses. This note takes a look at the impact of the epidemic at the macroeconomic and business...

|IB25
Ade Dosunmu, John McMillan
2001

Phyto-Riker, a U.S. investor-led start-up pharmaceutical company in Ghana, contemplates the effects of needs generated by the HIV epidemic in sub-Saharan Africa on its future business plans. In April 2001, it appeared as if political...

|P38
David Baron
2001

In an unprecedented move in mid-1998, Blue Cross of California, a unit of WeilPoint Health Networks, Inc., filed a Citizen Petition with the FDA to switch Claritin, manufactured by Schering Plough, and two other secondgeneration...